Novel motif:11: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif11_GCGANT
|novel_motifs_human_sample_pval=11376-118A8_11051;0.408795,11327-117E4_11969;0.900195,11473-119C6_11054;0.258204,11474-119C7_12067;0.35594...") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:32, 9 September 2013
name: | motif11_GCGANT |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0090304 | nucleic acid metabolic process | 9.785648e-14 |
GO:0016070 | RNA metabolic process | 2.177483e-12 |
GO:0010467 | gene expression | 2.363743e-11 |
GO:0070145 | mitochondrial asparaginyl-tRNA aminoacylation | 4.207133e-11 |
GO:0070127 | tRNA aminoacylation for mitochondrial protein translation | 2.650987e-10 |
GO:0032774 | RNA biosynthetic process | 4.453177e-10 |
GO:0034645 | cellular macromolecule biosynthetic process | 7.087149e-10 |
GO:0006351 | transcription, DNA-dependent | 9.989686e-10 |
GO:0090344 | negative regulation of cell aging | 3.873154e-9 |
GO:0009059 | macromolecule biosynthetic process | 8.082310e-9 |
GO:0018993 | somatic sex determination | 1.029644e-8 |
GO:0042703 | menstruation | 1.526232e-8 |
GO:0019101 | female somatic sex determination | 1.526232e-8 |
GO:0002074 | extraocular skeletal muscle development | 3.054101e-8 |
GO:0060976 | coronary vasculature development | 6.823395e-8 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 1.680827e-7 |
GO:0030262 | apoptotic nuclear change | 1.973230e-7 |
GO:0022601 | menstrual cycle phase | 2.170602e-7 |
GO:0006139 | nucleobase-containing compound metabolic process | 2.209934e-7 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 3.785952e-7 |
GO:0035470 | positive regulation of vascular wound healing | 3.920453e-7 |
GO:0000416 | positive regulation of histone H3-K36 methylation | 7.005150e-7 |
GO:0033326 | cerebrospinal fluid secretion | 8.586066e-7 |
GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter | 1.170705e-6 |
GO:0071934 | thiamine transmembrane transport | 1.208312e-6 |
GO:0006308 | DNA catabolic process | 1.775098e-6 |
GO:0006369 | termination of RNA polymerase II transcription | 1.814142e-6 |
GO:0060430 | lung saccule development | 2.307360e-6 |
GO:0032472 | Golgi calcium ion transport | 2.647295e-6 |
GO:0030026 | cellular manganese ion homeostasis | 2.647295e-6 |
GO:0032468 | Golgi calcium ion homeostasis | 2.647295e-6 |
GO:0010719 | negative regulation of epithelial to mesenchymal transition | 2.721571e-6 |
GO:0010871 | negative regulation of receptor biosynthetic process | 2.759228e-6 |
GO:0090342 | regulation of cell aging | 3.110080e-6 |
GO:0000413 | protein peptidyl-prolyl isomerization | 3.150744e-6 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 4.068174e-6 |
GO:0042538 | hyperosmotic salinity response | 5.442172e-6 |
GO:0032912 | negative regulation of transforming growth factor beta2 production | 5.590633e-6 |
GO:0000414 | regulation of histone H3-K36 methylation | 1.020732e-5 |
GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process | 1.042933e-5 |
GO:0010506 | regulation of autophagy | 1.368871e-5 |
GO:0016570 | histone modification | 1.429787e-5 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 1.626791e-5 |
GO:0018872 | arsonoacetate metabolic process | 1.626791e-5 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 1.693741e-5 |
GO:0014014 | negative regulation of gliogenesis | 1.716524e-5 |
GO:0043923 | positive regulation by host of viral transcription | 1.717535e-5 |
GO:0031123 | RNA 3'-end processing | 1.768288e-5 |
GO:0090102 | cochlea development | 1.827081e-5 |
GO:0044260 | cellular macromolecule metabolic process | 2.025335e-5 |
GO:0016569 | covalent chromatin modification | 2.069942e-5 |
GO:0010721 | negative regulation of cell development | 2.591736e-5 |
GO:0000959 | mitochondrial RNA metabolic process | 2.633486e-5 |
GO:0048713 | regulation of oligodendrocyte differentiation | 3.063423e-5 |
GO:0060014 | granulosa cell differentiation | 3.257000e-5 |
GO:0003310 | pancreatic A cell differentiation | 3.413695e-5 |
GO:0048561 | establishment of organ orientation | 3.577544e-5 |
GO:0043653 | mitochondrial fragmentation involved in apoptosis | 3.838518e-5 |
GO:0030237 | female sex determination | 3.838518e-5 |
GO:0003148 | outflow tract septum morphogenesis | 4.428788e-5 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 4.526061e-5 |
GO:0051252 | regulation of RNA metabolic process | 4.556728e-5 |
GO:0035886 | vascular smooth muscle cell differentiation | 5.791836e-5 |
GO:0060486 | Clara cell differentiation | 5.864098e-5 |
GO:0007208 | activation of phospholipase C activity by serotonin receptor signaling pathway | 6.079300e-5 |
GO:0009404 | toxin metabolic process | 6.148042e-5 |
GO:0006355 | regulation of transcription, DNA-dependent | 6.966198e-5 |
GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity | 7.364675e-5 |
GO:0065002 | intracellular protein transmembrane transport | 7.428523e-5 |
GO:0032042 | mitochondrial DNA metabolic process | 7.561485e-5 |
GO:0060980 | cell migration involved in coronary vasculogenesis | 7.566131e-5 |
GO:0035461 | vitamin transmembrane transport | 7.566131e-5 |
GO:0006302 | double-strand break repair | 7.627620e-5 |
GO:0060411 | cardiac septum morphogenesis | 8.083688e-5 |
GO:0090399 | replicative senescence | 8.154724e-5 |
GO:0000002 | mitochondrial genome maintenance | 8.584180e-5 |
GO:0000725 | recombinational repair | 9.288066e-5 |
GO:0000724 | double-strand break repair via homologous recombination | 9.491820e-5 |
GO:0006713 | glucocorticoid catabolic process | 9.833976e-5 |
GO:0006427 | histidyl-tRNA aminoacylation | 1.022055e-4 |
GO:0060712 | spongiotrophoblast layer development | 1.070824e-4 |
GO:0018293 | protein-FAD linkage | 1.075659e-4 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 1.075659e-4 |
GO:0033523 | histone H2B ubiquitination | 1.079278e-4 |
GO:0071539 | protein localization to centrosome | 1.092384e-4 |
GO:0006359 | regulation of transcription from RNA polymerase III promoter | 1.136020e-4 |
GO:0051890 | regulation of cardioblast differentiation | 1.136020e-4 |
GO:0022027 | interkinetic nuclear migration | 1.161655e-4 |
GO:0006513 | protein monoubiquitination | 1.176855e-4 |
GO:0000022 | mitotic spindle elongation | 1.177733e-4 |
GO:0071322 | cellular response to carbohydrate stimulus | 1.240380e-4 |
GO:0021759 | globus pallidus development | 1.295406e-4 |
GO:0006268 | DNA unwinding involved in replication | 1.379806e-4 |
GO:0042696 | menarche | 1.402571e-4 |
GO:0090303 | positive regulation of wound healing | 1.422469e-4 |
GO:0007141 | male meiosis I | 1.422469e-4 |
GO:0045892 | negative regulation of transcription, DNA-dependent | 1.473381e-4 |
GO:0090141 | positive regulation of mitochondrial fission | 1.579393e-4 |
GO:0052312 | modulation of transcription in other organism involved in symbiotic interaction | 1.610869e-4 |
GO:0048752 | semicircular canal morphogenesis | 1.641598e-4 |
GO:0034198 | cellular response to amino acid starvation | 1.706971e-4 |
GO:0006281 | DNA repair | 1.746315e-4 |
GO:0030421 | defecation | 1.768894e-4 |
GO:0035356 | cellular triglyceride homeostasis | 1.768894e-4 |
GO:0003309 | type B pancreatic cell differentiation | 1.842121e-4 |
GO:0055012 | ventricular cardiac muscle cell differentiation | 2.004571e-4 |
GO:0071333 | cellular response to glucose stimulus | 2.015802e-4 |
GO:0032383 | regulation of intracellular cholesterol transport | 2.051591e-4 |
GO:0051891 | positive regulation of cardioblast differentiation | 2.058539e-4 |
GO:0003279 | cardiac septum development | 2.062908e-4 |
GO:0051253 | negative regulation of RNA metabolic process | 2.172424e-4 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 2.256077e-4 |
GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process | 2.294442e-4 |
GO:0000715 | nucleotide-excision repair, DNA damage recognition | 2.371072e-4 |
GO:0046784 | intronless viral mRNA export from host nucleus | 2.399763e-4 |
GO:0060708 | spongiotrophoblast differentiation | 2.524990e-4 |
GO:0048664 | neuron fate determination | 2.650912e-4 |
GO:0002016 | regulation of blood volume by renin-angiotensin | 2.698269e-4 |
GO:0034339 | regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 2.730416e-4 |
GO:0018026 | peptidyl-lysine monomethylation | 2.780680e-4 |
GO:0060580 | ventral spinal cord interneuron fate determination | 2.809802e-4 |
GO:0003327 | type B pancreatic cell fate commitment | 2.809802e-4 |
GO:0003218 | cardiac left ventricle formation | 3.140122e-4 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 3.283591e-4 |
GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing | 3.283591e-4 |
GO:0006844 | acyl carnitine transport | 3.398709e-4 |
GO:0018208 | peptidyl-proline modification | 3.464187e-4 |
GO:0060596 | mammary placode formation | 3.631804e-4 |
GO:0043631 | RNA polyadenylation | 3.775128e-4 |
GO:0021530 | spinal cord oligodendrocyte cell fate specification | 3.966898e-4 |
GO:0010390 | histone monoubiquitination | 3.993697e-4 |
GO:0010629 | negative regulation of gene expression | 4.203211e-4 |
GO:0021604 | cranial nerve structural organization | 4.325982e-4 |
GO:0045686 | negative regulation of glial cell differentiation | 4.353674e-4 |
GO:0032392 | DNA geometric change | 4.375969e-4 |
GO:0000236 | mitotic prometaphase | 4.663337e-4 |
GO:0051083 | 'de novo' cotranslational protein folding | 4.667663e-4 |
GO:0070159 | mitochondrial threonyl-tRNA aminoacylation | 4.701855e-4 |
GO:0002882 | positive regulation of chronic inflammatory response to non-antigenic stimulus | 4.701855e-4 |
GO:0043622 | cortical microtubule organization | 4.701855e-4 |
GO:0031658 | negative regulation of cyclin-dependent protein kinase activity involved in G1/S | 4.701855e-4 |
GO:0007092 | activation of mitotic anaphase-promoting complex activity | 4.701855e-4 |
GO:0030103 | vasopressin secretion | 4.701855e-4 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 4.928205e-4 |
GO:0035845 | photoreceptor cell outer segment organization | 4.981679e-4 |
GO:0010983 | positive regulation of high-density lipoprotein particle clearance | 4.981679e-4 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 5.009664e-4 |
GO:0009446 | putrescine biosynthetic process | 5.318934e-4 |
GO:2000615 | regulation of histone H3-K9 acetylation | 5.431450e-4 |
GO:0060510 | Type II pneumocyte differentiation | 6.036798e-4 |
GO:0003151 | outflow tract morphogenesis | 6.164186e-4 |
GO:0048714 | positive regulation of oligodendrocyte differentiation | 6.378048e-4 |
GO:0006481 | C-terminal protein methylation | 6.479560e-4 |
GO:0042984 | regulation of amyloid precursor protein biosynthetic process | 6.489600e-4 |
GO:0045685 | regulation of glial cell differentiation | 6.595789e-4 |
GO:0006378 | mRNA polyadenylation | 6.786361e-4 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 6.873577e-4 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 6.876252e-4 |
GO:0031122 | cytoplasmic microtubule organization | 7.201044e-4 |
GO:0016574 | histone ubiquitination | 7.202207e-4 |
GO:0009086 | methionine biosynthetic process | 7.421434e-4 |
GO:0000966 | RNA 5'-end processing | 7.509299e-4 |
GO:0090140 | regulation of mitochondrial fission | 7.751763e-4 |
GO:0006289 | nucleotide-excision repair | 7.833264e-4 |
GO:0061084 | negative regulation of protein refolding | 7.851454e-4 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 7.886399e-4 |
GO:0016140 | O-glycoside metabolic process | 8.017807e-4 |
GO:0035115 | embryonic forelimb morphogenesis | 8.337700e-4 |
GO:0021612 | facial nerve structural organization | 8.642693e-4 |
GO:0043000 | Golgi to plasma membrane CFTR protein transport | 9.184677e-4 |
GO:0000375 | RNA splicing, via transesterification reactions | 9.199354e-4 |
GO:0006493 | protein O-linked glycosylation | 9.247099e-4 |
GO:0031124 | mRNA 3'-end processing | 9.298239e-4 |
GO:0070535 | histone H2A K63-linked ubiquitination | 9.729706e-4 |
GO:0046210 | nitric oxide catabolic process | 9.729706e-4 |
GO:0090346 | cellular organofluorine metabolic process | 9.729706e-4 |
GO:0043602 | nitrate catabolic process | 9.729706e-4 |
GO:0035621 | ER to Golgi ceramide transport | 9.729706e-4 |
GO:0042732 | D-xylose metabolic process | 9.729706e-4 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 9.881287e-4 |
GO:0006270 | DNA-dependent DNA replication initiation | 9.986338e-4 |
GO:0016926 | protein desumoylation | 1.008388e-3 |
GO:0048486 | parasympathetic nervous system development | 1.011177e-3 |
GO:0014013 | regulation of gliogenesis | 1.030502e-3 |
GO:0035567 | non-canonical Wnt receptor signaling pathway | 1.049862e-3 |
GO:0010159 | specification of organ position | 1.086926e-3 |
GO:0070534 | protein K63-linked ubiquitination | 1.094629e-3 |
GO:0007199 | G-protein signaling, coupled to cGMP nucleotide second messenger | 1.111756e-3 |
GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process | 1.111838e-3 |
GO:0032446 | protein modification by small protein conjugation | 1.185843e-3 |
GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition | 1.234204e-3 |
GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation | 1.234204e-3 |
GO:0042711 | maternal behavior | 1.283081e-3 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 1.306681e-3 |
GO:0002035 | brain renin-angiotensin system | 1.308918e-3 |
GO:0035117 | embryonic arm morphogenesis | 1.312225e-3 |
GO:0060412 | ventricular septum morphogenesis | 1.361174e-3 |
GO:0002115 | store-operated calcium entry | 1.408399e-3 |
GO:0046884 | follicle-stimulating hormone secretion | 1.409926e-3 |
GO:0032275 | luteinizing hormone secretion | 1.409926e-3 |
GO:0000729 | DNA double-strand break processing | 1.410167e-3 |
GO:0006264 | mitochondrial DNA replication | 1.464808e-3 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 1.488647e-3 |
GO:0051865 | protein autoubiquitination | 1.514835e-3 |
GO:0061351 | neural precursor cell proliferation | 1.523224e-3 |
GO:0090224 | regulation of spindle organization | 1.528923e-3 |
GO:0070584 | mitochondrion morphogenesis | 1.557414e-3 |
GO:0010890 | positive regulation of sequestering of triglyceride | 1.572174e-3 |
GO:0006290 | pyrimidine dimer repair | 1.572174e-3 |
GO:0050779 | RNA destabilization | 1.572454e-3 |
GO:0000097 | sulfur amino acid biosynthetic process | 1.573519e-3 |
GO:0021666 | rhombomere 5 formation | 1.581101e-3 |
GO:0021660 | rhombomere 3 formation | 1.581101e-3 |
GO:0071105 | response to interleukin-11 | 1.615777e-3 |
GO:0042946 | glucoside transport | 1.615777e-3 |
GO:0019358 | nicotinate nucleotide salvage | 1.615777e-3 |
GO:0023035 | CD40 signaling pathway | 1.615777e-3 |
GO:0032508 | DNA duplex unwinding | 1.674551e-3 |
GO:0043921 | modulation by host of viral transcription | 1.720203e-3 |
GO:0021599 | abducens nerve formation | 1.818490e-3 |
GO:0007634 | optokinetic behavior | 1.818490e-3 |
GO:0042823 | pyridoxal phosphate biosynthetic process | 1.901625e-3 |
GO:0019348 | dolichol metabolic process | 1.901625e-3 |
GO:0007174 | epidermal growth factor catabolic process | 1.901625e-3 |
GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly | 1.901625e-3 |
GO:2000620 | positive regulation of histone H4-K16 acetylation | 1.906015e-3 |
GO:2000617 | positive regulation of histone H3-K9 acetylation | 1.906015e-3 |
GO:0070625 | zymogen granule exocytosis | 1.906015e-3 |
GO:0070512 | positive regulation of histone H4-K20 methylation | 1.906015e-3 |
GO:0030505 | inorganic diphosphate transport | 1.910346e-3 |
GO:0035566 | regulation of metanephros size | 1.919203e-3 |
GO:0015870 | acetylcholine transport | 1.919203e-3 |
GO:0010701 | positive regulation of norepinephrine secretion | 1.919203e-3 |
GO:0016925 | protein sumoylation | 1.923835e-3 |
GO:0061001 | regulation of dendritic spine morphogenesis | 1.953489e-3 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 2.057173e-3 |
GO:0050746 | regulation of lipoprotein metabolic process | 2.269619e-3 |
GO:0021783 | preganglionic parasympathetic nervous system development | 2.272114e-3 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 2.292347e-3 |
GO:0019509 | L-methionine salvage from methylthioadenosine | 2.292347e-3 |
GO:0042723 | thiamine-containing compound metabolic process | 2.294552e-3 |
GO:0006379 | mRNA cleavage | 2.296149e-3 |
GO:0021602 | cranial nerve morphogenesis | 2.335646e-3 |
GO:0060876 | semicircular canal formation | 2.351237e-3 |
GO:0048712 | negative regulation of astrocyte differentiation | 2.423348e-3 |
GO:0072300 | positive regulation of metanephric glomerulus development | 2.501786e-3 |
GO:0021603 | cranial nerve formation | 2.505235e-3 |
GO:0060253 | negative regulation of glial cell proliferation | 2.551620e-3 |
GO:0010735 | positive regulation of transcription via serum response element binding | 2.570850e-3 |
GO:0006348 | chromatin silencing at telomere | 2.571621e-3 |
GO:0043415 | positive regulation of skeletal muscle tissue regeneration | 2.585008e-3 |
GO:0016567 | protein ubiquitination | 2.659723e-3 |
GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter | 2.780700e-3 |
GO:0042797 | tRNA transcription from RNA polymerase III promoter | 2.780700e-3 |
GO:0042843 | D-xylose catabolic process | 2.801690e-3 |
GO:0051571 | positive regulation of histone H3-K4 methylation | 2.826628e-3 |
GO:0003281 | ventricular septum development | 2.853926e-3 |
GO:0060872 | semicircular canal development | 2.865791e-3 |
GO:0072086 | specification of loop of Henle identity | 2.874787e-3 |
GO:0061013 | regulation of mRNA catabolic process | 2.913656e-3 |
GO:0042772 | DNA damage response, signal transduction resulting in transcription | 2.913656e-3 |
GO:0016568 | chromatin modification | 2.980253e-3 |
GO:0043697 | cell dedifferentiation | 3.006954e-3 |
GO:2000773 | negative regulation of cellular senescence | 3.006954e-3 |
GO:0030953 | astral microtubule organization | 3.006954e-3 |
GO:0051645 | Golgi localization | 3.071631e-3 |
GO:0006421 | asparaginyl-tRNA aminoacylation | 3.071631e-3 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 3.077267e-3 |
GO:0002017 | regulation of blood volume by renal aldosterone | 3.077267e-3 |
GO:0085020 | protein K6-linked ubiquitination | 3.077688e-3 |
GO:0048102 | autophagic cell death | 3.077688e-3 |
GO:0045116 | protein neddylation | 3.077688e-3 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 3.105485e-3 |
GO:0007158 | neuron cell-cell adhesion | 3.113728e-3 |
GO:0007501 | mesodermal cell fate specification | 3.138047e-3 |
GO:0001678 | cellular glucose homeostasis | 3.141660e-3 |
GO:0001941 | postsynaptic membrane organization | 3.194506e-3 |
GO:0090179 | planar cell polarity pathway involved in neural tube closure | 3.227265e-3 |
GO:0071476 | cellular hypotonic response | 3.249408e-3 |
GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly | 3.256630e-3 |
GO:0015872 | dopamine transport | 3.288828e-3 |
GO:0060713 | labyrinthine layer morphogenesis | 3.337052e-3 |
GO:0043508 | negative regulation of JUN kinase activity | 3.352366e-3 |
GO:0090103 | cochlea morphogenesis | 3.364970e-3 |
GO:0042073 | intraflagellar transport | 3.483672e-3 |
GO:0009067 | aspartate family amino acid biosynthetic process | 3.582195e-3 |
GO:0035928 | rRNA import into mitochondrion | 3.586770e-3 |
GO:0000422 | mitochondrion degradation | 3.611667e-3 |
GO:0033182 | regulation of histone ubiquitination | 3.629010e-3 |
GO:0051315 | attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation | 3.629010e-3 |
GO:0006666 | 3-keto-sphinganine metabolic process | 3.629010e-3 |
GO:0043401 | steroid hormone mediated signaling pathway | 3.707833e-3 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 3.742288e-3 |
GO:0048291 | isotype switching to IgG isotypes | 3.742288e-3 |
GO:0002368 | B cell cytokine production | 3.742288e-3 |
GO:0006555 | methionine metabolic process | 3.751616e-3 |
GO:0060039 | pericardium development | 3.756068e-3 |
GO:0051973 | positive regulation of telomerase activity | 3.808871e-3 |
GO:0048388 | endosomal lumen acidification | 3.896471e-3 |
GO:0003326 | pancreatic A cell fate commitment | 3.896471e-3 |
GO:0003329 | pancreatic PP cell fate commitment | 3.896471e-3 |
GO:0021542 | dentate gyrus development | 3.920734e-3 |
GO:0007140 | male meiosis | 3.937474e-3 |
GO:0030488 | tRNA methylation | 3.987492e-3 |
GO:0015884 | folic acid transport | 3.991928e-3 |
GO:0032202 | telomere assembly | 3.991928e-3 |
GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation | 4.033869e-3 |
GO:0042596 | fear response | 4.067954e-3 |
GO:0035357 | peroxisome proliferator activated receptor signaling pathway | 4.111589e-3 |
GO:0033057 | multicellular organismal reproductive behavior | 4.155046e-3 |
GO:0035441 | cell migration involved in vasculogenesis | 4.169912e-3 |
GO:0060592 | mammary gland formation | 4.230558e-3 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 4.232796e-3 |
GO:0060998 | regulation of dendritic spine development | 4.361709e-3 |
GO:0009890 | negative regulation of biosynthetic process | 4.456602e-3 |
GO:0048691 | positive regulation of axon extension involved in regeneration | 4.479035e-3 |
GO:0019056 | modulation by virus of host transcription | 4.479035e-3 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 4.564661e-3 |
GO:0007181 | transforming growth factor beta receptor complex assembly | 4.565908e-3 |
GO:0030520 | estrogen receptor signaling pathway | 4.581348e-3 |
GO:0046602 | regulation of mitotic centrosome separation | 4.609794e-3 |
GO:0030388 | fructose 1,6-bisphosphate metabolic process | 4.685505e-3 |
GO:0090239 | regulation of histone H4 acetylation | 4.765613e-3 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 4.893474e-3 |
GO:0006501 | C-terminal protein lipidation | 4.982199e-3 |
GO:0007231 | osmosensory signaling pathway | 5.042351e-3 |
GO:0034641 | cellular nitrogen compound metabolic process | 5.075903e-3 |
GO:0071104 | response to interleukin-9 | 5.081615e-3 |
GO:0045875 | negative regulation of sister chromatid cohesion | 5.081615e-3 |
GO:0060044 | negative regulation of cardiac muscle cell proliferation | 5.173569e-3 |
GO:0048532 | anatomical structure arrangement | 5.229279e-3 |
GO:0051276 | chromosome organization | 5.298003e-3 |
GO:0003181 | atrioventricular valve morphogenesis | 5.320049e-3 |
GO:0021571 | rhombomere 5 development | 5.331188e-3 |
GO:0051569 | regulation of histone H3-K4 methylation | 5.423888e-3 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 5.447468e-3 |
GO:2000772 | regulation of cellular senescence | 5.504066e-3 |
GO:0055014 | atrial cardiac muscle cell development | 5.529754e-3 |
GO:0060977 | coronary vasculature morphogenesis | 5.529754e-3 |
GO:0048715 | negative regulation of oligodendrocyte differentiation | 5.544243e-3 |
GO:0045626 | negative regulation of T-helper 1 cell differentiation | 5.551219e-3 |
GO:0072331 | signal transduction by p53 class mediator | 5.640510e-3 |
GO:0001710 | mesodermal cell fate commitment | 5.689626e-3 |
GO:0001764 | neuron migration | 5.898398e-3 |
GO:0009304 | tRNA transcription | 5.911965e-3 |
GO:0002065 | columnar/cuboidal epithelial cell differentiation | 5.933224e-3 |
GO:0060383 | positive regulation of DNA strand elongation | 5.935611e-3 |
GO:0042694 | muscle cell fate specification | 5.935611e-3 |
GO:0051660 | establishment of centrosome localization | 5.935611e-3 |
GO:0042335 | cuticle development | 5.935611e-3 |
GO:0021540 | corpus callosum morphogenesis | 5.935611e-3 |
GO:0010986 | positive regulation of lipoprotein particle clearance | 5.935611e-3 |
GO:0009996 | negative regulation of cell fate specification | 6.042738e-3 |
GO:0006999 | nuclear pore organization | 6.087458e-3 |
GO:0016048 | detection of temperature stimulus | 6.138037e-3 |
GO:0021610 | facial nerve morphogenesis | 6.139089e-3 |
GO:0021895 | cerebral cortex neuron differentiation | 6.171627e-3 |
GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity | 6.219479e-3 |
GO:0010468 | regulation of gene expression | 6.244949e-3 |
GO:0042228 | interleukin-8 biosynthetic process | 6.285050e-3 |
GO:0000088 | mitotic prophase | 6.285050e-3 |
GO:0033342 | negative regulation of collagen binding | 6.285050e-3 |
GO:0008380 | RNA splicing | 6.294850e-3 |
GO:0046333 | octopamine metabolic process | 6.331215e-3 |
GO:0042309 | homoiothermy | 6.331215e-3 |
GO:0046950 | cellular ketone body metabolic process | 6.331380e-3 |
GO:0007422 | peripheral nervous system development | 6.358094e-3 |
GO:0034770 | histone H4-K20 methylation | 6.408837e-3 |
GO:0003206 | cardiac chamber morphogenesis | 6.551617e-3 |
GO:0097039 | protein linear polyubiquitination | 6.641896e-3 |
GO:0002678 | positive regulation of chronic inflammatory response | 6.786646e-3 |
GO:0035136 | forelimb morphogenesis | 6.899134e-3 |
GO:0061014 | positive regulation of mRNA catabolic process | 7.087373e-3 |
GO:0003323 | type B pancreatic cell development | 7.096367e-3 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 7.293166e-3 |
GO:0070407 | oxidation-dependent protein catabolic process | 7.318351e-3 |
GO:0051106 | positive regulation of DNA ligation | 7.318351e-3 |
GO:2000252 | negative regulation of feeding behavior | 7.318351e-3 |
GO:0002033 | vasodilation by angiotensin involved in regulation of systemic arterial blood pressure | 7.318351e-3 |
GO:0019061 | uncoating of virus | 7.318351e-3 |
GO:0042414 | epinephrine metabolic process | 7.318351e-3 |
GO:0043456 | regulation of pentose-phosphate shunt | 7.341282e-3 |
GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation | 7.341282e-3 |
GO:0035166 | post-embryonic hemopoiesis | 7.418881e-3 |
GO:0090234 | regulation of kinetochore assembly | 7.504813e-3 |
GO:0090169 | regulation of spindle assembly | 7.504813e-3 |
GO:0021846 | cell proliferation in forebrain | 7.536632e-3 |
GO:0006853 | carnitine shuttle | 7.672062e-3 |
GO:0006479 | protein methylation | 7.682371e-3 |
GO:2000119 | negative regulation of sodium-dependent phosphate transport | 7.804236e-3 |
GO:0034699 | response to luteinizing hormone stimulus | 7.804236e-3 |
GO:0008295 | spermidine biosynthetic process | 7.804236e-3 |
GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly | 8.210944e-3 |
GO:0009443 | pyridoxal 5'-phosphate salvage | 8.210944e-3 |
GO:0042989 | sequestering of actin monomers | 8.275211e-3 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 8.435862e-3 |
GO:0060706 | cell differentiation involved in embryonic placenta development | 8.441532e-3 |
GO:0071425 | hemopoietic stem cell proliferation | 8.525532e-3 |
GO:0044339 | canonical Wnt receptor signaling pathway involved in osteoblast differentiation | 8.568670e-3 |
GO:0044338 | canonical Wnt receptor signaling pathway involved in mesenchymal stem cell differentiation | 8.568670e-3 |
GO:0032543 | mitochondrial translation | 8.609603e-3 |
GO:0002209 | behavioral defense response | 8.628102e-3 |
GO:0035721 | intraflagellar retrograde transport | 8.719202e-3 |
GO:0051647 | nucleus localization | 8.728723e-3 |
GO:0000738 | DNA catabolic process, exonucleolytic | 8.736168e-3 |
GO:0021562 | vestibulocochlear nerve development | 9.033058e-3 |
GO:0034214 | protein hexamerization | 9.173304e-3 |
GO:0000726 | non-recombinational repair | 9.207801e-3 |
GO:0034695 | response to prostaglandin E stimulus | 9.418741e-3 |
GO:0050774 | negative regulation of dendrite morphogenesis | 9.819198e-3 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 9.909989e-3 |
GO:0051457 | maintenance of protein location in nucleus | 9.980167e-3 |
GO:0060304 | regulation of phosphatidylinositol dephosphorylation | 1.011353e-2 |
GO:0071279 | cellular response to cobalt ion | 1.011353e-2 |
GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process | 1.011353e-2 |
GO:0032074 | negative regulation of nuclease activity | 1.011353e-2 |
GO:0031119 | tRNA pseudouridine synthesis | 1.011353e-2 |
GO:0010637 | negative regulation of mitochondrial fusion | 1.011353e-2 |
GO:0003416 | endochondral bone growth | 1.032119e-2 |
GO:0010560 | positive regulation of glycoprotein biosynthetic process | 1.034111e-2 |
GO:0032861 | activation of Rap GTPase activity | 1.057973e-2 |
GO:0018393 | internal peptidyl-lysine acetylation | 1.058234e-2 |
GO:0071985 | multivesicular body sorting pathway | 1.077582e-2 |
GO:0018022 | peptidyl-lysine methylation | 1.077582e-2 |
GO:0060648 | mammary gland bud morphogenesis | 1.098045e-2 |
GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase | 1.098045e-2 |
GO:0048663 | neuron fate commitment | 1.102541e-2 |
GO:0001732 | formation of translation initiation complex | 1.112184e-2 |
GO:0032911 | negative regulation of transforming growth factor beta1 production | 1.117039e-2 |
GO:0010626 | negative regulation of Schwann cell proliferation | 1.119484e-2 |
GO:0046755 | non-lytic virus budding | 1.124498e-2 |
GO:0090219 | negative regulation of lipid kinase activity | 1.146707e-2 |
GO:0006499 | N-terminal protein myristoylation | 1.146707e-2 |
GO:0042631 | cellular response to water deprivation | 1.146707e-2 |
GO:0045739 | positive regulation of DNA repair | 1.157296e-2 |
GO:0015842 | synaptic vesicle amine transport | 1.173106e-2 |
GO:0035425 | autocrine signaling | 1.173106e-2 |
GO:0034498 | early endosome to Golgi transport | 1.188421e-2 |
GO:0030302 | deoxynucleotide transport | 1.188421e-2 |
GO:0060742 | epithelial cell differentiation involved in prostate gland development | 1.190793e-2 |
GO:0006261 | DNA-dependent DNA replication | 1.217577e-2 |
GO:0003166 | bundle of His development | 1.217960e-2 |
GO:0060687 | regulation of branching involved in prostate gland morphogenesis | 1.236146e-2 |
GO:0045819 | positive regulation of glycogen catabolic process | 1.239544e-2 |
GO:0021561 | facial nerve development | 1.257756e-2 |
GO:0003417 | growth plate cartilage development | 1.269156e-2 |
GO:0045403 | negative regulation of interleukin-4 biosynthetic process | 1.273069e-2 |
GO:0034351 | negative regulation of glial cell apoptosis | 1.273069e-2 |
GO:0060377 | negative regulation of mast cell differentiation | 1.273069e-2 |
GO:0002295 | T-helper cell lineage commitment | 1.273069e-2 |
GO:0003195 | tricuspid valve formation | 1.273069e-2 |
GO:0003192 | mitral valve formation | 1.273069e-2 |
GO:0001662 | behavioral fear response | 1.275369e-2 |
GO:0046605 | regulation of centrosome cycle | 1.301079e-2 |
GO:0072081 | specification of nephron tubule identity | 1.312472e-2 |
GO:0050768 | negative regulation of neurogenesis | 1.328083e-2 |
GO:0044249 | cellular biosynthetic process | 1.331504e-2 |
GO:0034644 | cellular response to UV | 1.332719e-2 |
GO:0018394 | peptidyl-lysine acetylation | 1.340576e-2 |
GO:0060669 | embryonic placenta morphogenesis | 1.344214e-2 |
GO:0032224 | positive regulation of synaptic transmission, cholinergic | 1.377938e-2 |
GO:0046939 | nucleotide phosphorylation | 1.383665e-2 |
GO:0018027 | peptidyl-lysine dimethylation | 1.386891e-2 |
GO:0032203 | telomere formation via telomerase | 1.386891e-2 |
GO:0005981 | regulation of glycogen catabolic process | 1.399574e-2 |
GO:0035435 | phosphate ion transmembrane transport | 1.409870e-2 |
GO:0002118 | aggressive behavior | 1.410381e-2 |
GO:0010950 | positive regulation of endopeptidase activity | 1.410381e-2 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 1.420917e-2 |
GO:0010266 | response to vitamin B1 | 1.420917e-2 |
GO:0090129 | positive regulation of synapse maturation | 1.422413e-2 |
GO:0006686 | sphingomyelin biosynthetic process | 1.426252e-2 |
GO:0071866 | negative regulation of apoptosis in bone marrow | 1.431815e-2 |
GO:0071864 | positive regulation of cell proliferation in bone marrow | 1.431815e-2 |
GO:0071482 | cellular response to light stimulus | 1.445753e-2 |
GO:0006595 | polyamine metabolic process | 1.445753e-2 |
GO:0031327 | negative regulation of cellular biosynthetic process | 1.496942e-2 |
GO:0042418 | epinephrine biosynthetic process | 1.497529e-2 |
GO:0042780 | tRNA 3'-end processing | 1.497529e-2 |
GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation | 1.497529e-2 |
GO:0035852 | horizontal cell localization | 1.497529e-2 |
GO:0048855 | adenohypophysis morphogenesis | 1.497529e-2 |
GO:0031118 | rRNA pseudouridine synthesis | 1.497529e-2 |
GO:0006585 | dopamine biosynthetic process from tyrosine | 1.497529e-2 |
GO:0035502 | metanephric ureteric bud development | 1.497529e-2 |
GO:0035846 | oviduct epithelium development | 1.497529e-2 |
GO:0035849 | nephric duct elongation | 1.497529e-2 |
GO:0035847 | uterine epithelium development | 1.497529e-2 |
GO:0035090 | maintenance of apical/basal cell polarity | 1.526457e-2 |
GO:0061302 | smooth muscle cell-matrix adhesion | 1.534457e-2 |
GO:0045472 | response to ether | 1.534457e-2 |
GO:0032205 | negative regulation of telomere maintenance | 1.543315e-2 |
GO:0052066 | entry of symbiont into host cell by promotion of host phagocytosis | 1.545530e-2 |
GO:0060060 | post-embryonic retina morphogenesis in camera-type eye | 1.545530e-2 |
GO:0035635 | entry of bacterium into host cell | 1.545530e-2 |
GO:0046358 | butyrate biosynthetic process | 1.545530e-2 |
GO:0033566 | gamma-tubulin complex localization | 1.545530e-2 |
GO:0090128 | regulation of synapse maturation | 1.578579e-2 |
GO:0018410 | C-terminal protein amino acid modification | 1.591586e-2 |
GO:0046174 | polyol catabolic process | 1.611574e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0006396 | RNA processing | 1.047096e-12 |
GO:0051891 | positive regulation of cardioblast differentiation | 4.999865e-10 |
GO:0006397 | mRNA processing | 1.497584e-9 |
GO:0008380 | RNA splicing | 1.676715e-9 |
GO:0016071 | mRNA metabolic process | 8.980478e-9 |
GO:0051890 | regulation of cardioblast differentiation | 1.303776e-8 |
GO:0006268 | DNA unwinding involved in replication | 1.520012e-8 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 9.315404e-8 |
GO:0090304 | nucleic acid metabolic process | 1.005139e-7 |
GO:0032508 | DNA duplex unwinding | 1.585576e-7 |
GO:0032392 | DNA geometric change | 2.977910e-7 |
GO:0032912 | negative regulation of transforming growth factor beta2 production | 3.149625e-7 |
GO:0006540 | glutamate decarboxylation to succinate | 3.390562e-7 |
GO:0006261 | DNA-dependent DNA replication | 4.471442e-7 |
GO:0022402 | cell cycle process | 5.507341e-7 |
GO:0031508 | centromeric heterochromatin formation | 6.524530e-7 |
GO:0045666 | positive regulation of neuron differentiation | 7.570158e-7 |
GO:0016070 | RNA metabolic process | 7.673208e-7 |
GO:0003309 | type B pancreatic cell differentiation | 8.197456e-7 |
GO:0010467 | gene expression | 1.262798e-6 |
GO:0006260 | DNA replication | 1.352369e-6 |
GO:0090234 | regulation of kinetochore assembly | 1.574817e-6 |
GO:0090169 | regulation of spindle assembly | 1.574817e-6 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 1.634354e-6 |
GO:0060045 | positive regulation of cardiac muscle cell proliferation | 1.922301e-6 |
GO:0085020 | protein K6-linked ubiquitination | 2.113415e-6 |
GO:0072040 | negative regulation of mesenchymal stem cell apoptosis involved in nephron morphogenesis | 2.796691e-6 |
GO:0042254 | ribosome biogenesis | 2.934493e-6 |
GO:0000086 | G2/M transition of mitotic cell cycle | 3.000624e-6 |
GO:0000278 | mitotic cell cycle | 3.155063e-6 |
GO:0042136 | neurotransmitter biosynthetic process | 3.239917e-6 |
GO:0060043 | regulation of cardiac muscle cell proliferation | 3.992155e-6 |
GO:0030513 | positive regulation of BMP signaling pathway | 4.536171e-6 |
GO:0007493 | endodermal cell fate determination | 4.608369e-6 |
GO:0051726 | regulation of cell cycle | 5.083899e-6 |
GO:0022403 | cell cycle phase | 9.043701e-6 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 9.218843e-6 |
GO:0007141 | male meiosis I | 1.178817e-5 |
GO:0090231 | regulation of spindle checkpoint | 1.193761e-5 |
GO:0000080 | G1 phase of mitotic cell cycle | 1.204441e-5 |
GO:0046853 | inositol or phosphatidylinositol phosphorylation | 1.368831e-5 |
GO:0006538 | glutamate catabolic process | 1.730079e-5 |
GO:0031577 | spindle checkpoint | 1.998747e-5 |
GO:0035621 | ER to Golgi ceramide transport | 2.078085e-5 |
GO:0003310 | pancreatic A cell differentiation | 2.212185e-5 |
GO:0006139 | nucleobase-containing compound metabolic process | 2.220628e-5 |
GO:0016072 | rRNA metabolic process | 2.382716e-5 |
GO:0061013 | regulation of mRNA catabolic process | 2.550978e-5 |
GO:0000726 | non-recombinational repair | 2.800215e-5 |
GO:0021562 | vestibulocochlear nerve development | 3.231594e-5 |
GO:0045931 | positive regulation of mitotic cell cycle | 3.268577e-5 |
GO:0090193 | positive regulation of glomerulus development | 3.517402e-5 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 4.208364e-5 |
GO:0060795 | cell fate commitment involved in formation of primary germ layers | 4.225463e-5 |
GO:0006657 | CDP-choline pathway | 4.373246e-5 |
GO:0055021 | regulation of cardiac muscle tissue growth | 4.659277e-5 |
GO:0022613 | ribonucleoprotein complex biogenesis | 4.756634e-5 |
GO:0035886 | vascular smooth muscle cell differentiation | 5.040265e-5 |
GO:0071169 | establishment of protein localization to chromatin | 5.584497e-5 |
GO:0045078 | positive regulation of interferon-gamma biosynthetic process | 5.710903e-5 |
GO:0044265 | cellular macromolecule catabolic process | 5.780036e-5 |
GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing | 5.979212e-5 |
GO:0033031 | positive regulation of neutrophil apoptosis | 6.301936e-5 |
GO:0070165 | positive regulation of adiponectin secretion | 6.301936e-5 |
GO:0006308 | DNA catabolic process | 6.840239e-5 |
GO:0071843 | cellular component biogenesis at cellular level | 7.671880e-5 |
GO:0045072 | regulation of interferon-gamma biosynthetic process | 7.917338e-5 |
GO:0007049 | cell cycle | 9.324830e-5 |
GO:0003148 | outflow tract septum morphogenesis | 9.387677e-5 |
GO:0051329 | interphase of mitotic cell cycle | 1.013098e-4 |
GO:0032465 | regulation of cytokinesis | 1.021745e-4 |
GO:2000594 | positive regulation of metanephric DCT cell differentiation | 1.093012e-4 |
GO:0072305 | negative regulation of mesenchymal stem cell apoptosis involved in metanephric nephron morphogenesis | 1.093012e-4 |
GO:0039003 | pronephric field specification | 1.093012e-4 |
GO:0001711 | endodermal cell fate commitment | 1.103682e-4 |
GO:0034661 | ncRNA catabolic process | 1.170912e-4 |
GO:0034446 | substrate adhesion-dependent cell spreading | 1.176136e-4 |
GO:0051030 | snRNA transport | 1.190684e-4 |
GO:0046416 | D-amino acid metabolic process | 1.190684e-4 |
GO:0060411 | cardiac septum morphogenesis | 1.243796e-4 |
GO:0072300 | positive regulation of metanephric glomerulus development | 1.386563e-4 |
GO:0051318 | G1 phase | 1.493556e-4 |
GO:0006364 | rRNA processing | 1.561927e-4 |
GO:0003279 | cardiac septum development | 1.645842e-4 |
GO:0032911 | negative regulation of transforming growth factor beta1 production | 1.673001e-4 |
GO:0072003 | kidney rudiment formation | 1.708894e-4 |
GO:0014010 | Schwann cell proliferation | 1.708894e-4 |
GO:0018243 | protein O-linked glycosylation via threonine | 1.809295e-4 |
GO:0018242 | protein O-linked glycosylation via serine | 1.809295e-4 |
GO:0051297 | centrosome organization | 1.810631e-4 |
GO:0019428 | allantoin biosynthetic process | 1.957979e-4 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.996621e-4 |
GO:0051325 | interphase | 2.041274e-4 |
GO:0061360 | optic chiasma development | 2.204943e-4 |
GO:2000597 | positive regulation of optic nerve formation | 2.204943e-4 |
GO:0021650 | vestibulocochlear nerve formation | 2.204943e-4 |
GO:0035799 | ureter maturation | 2.204943e-4 |
GO:0021633 | optic nerve structural organization | 2.204943e-4 |
GO:0001709 | cell fate determination | 2.231171e-4 |
GO:0032908 | regulation of transforming growth factor beta1 production | 2.295567e-4 |
GO:0006259 | DNA metabolic process | 2.401689e-4 |
GO:0009452 | RNA capping | 2.441800e-4 |
GO:0000237 | leptotene | 2.533517e-4 |
GO:0072205 | metanephric collecting duct development | 2.613612e-4 |
GO:0070534 | protein K63-linked ubiquitination | 2.659318e-4 |
GO:0044260 | cellular macromolecule metabolic process | 2.684548e-4 |
GO:0070830 | tight junction assembly | 2.906320e-4 |
GO:0090224 | regulation of spindle organization | 3.238779e-4 |
GO:0046491 | L-methylmalonyl-CoA metabolic process | 3.325888e-4 |
GO:0016078 | tRNA catabolic process | 3.325888e-4 |
GO:0001682 | tRNA 5'-leader removal | 3.325888e-4 |
GO:0055024 | regulation of cardiac muscle tissue development | 3.387387e-4 |
GO:0021884 | forebrain neuron development | 3.459446e-4 |
GO:0006413 | translational initiation | 3.477753e-4 |
GO:0048645 | organ formation | 3.484147e-4 |
GO:0034587 | piRNA metabolic process | 3.726247e-4 |
GO:0003197 | endocardial cushion development | 3.746132e-4 |
GO:0007099 | centriole replication | 3.840955e-4 |
GO:0071034 | CUT catabolic process | 3.843990e-4 |
GO:0048286 | lung alveolus development | 3.849324e-4 |
GO:0071173 | spindle assembly checkpoint | 3.882960e-4 |
GO:2000036 | regulation of stem cell maintenance | 3.997796e-4 |
GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis | 4.251243e-4 |
GO:0071777 | positive regulation of cell cycle cytokinesis | 4.612482e-4 |
GO:0006289 | nucleotide-excision repair | 4.659006e-4 |
GO:0060575 | intestinal epithelial cell differentiation | 4.672281e-4 |
GO:0050668 | positive regulation of homocysteine metabolic process | 4.700843e-4 |
GO:0045963 | negative regulation of dopamine metabolic process | 4.700843e-4 |
GO:0001704 | formation of primary germ layer | 4.707828e-4 |
GO:0007140 | male meiosis | 4.795595e-4 |
GO:0010564 | regulation of cell cycle process | 5.299098e-4 |
GO:0070079 | histone H4-R3 demethylation | 5.319094e-4 |
GO:0070078 | histone H3-R2 demethylation | 5.319094e-4 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 5.319094e-4 |
GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 5.319094e-4 |
GO:0022417 | protein maturation by protein folding | 5.319094e-4 |
GO:0046882 | negative regulation of follicle-stimulating hormone secretion | 5.356314e-4 |
GO:0046426 | negative regulation of JAK-STAT cascade | 5.418390e-4 |
GO:0031023 | microtubule organizing center organization | 5.422172e-4 |
GO:0035987 | endodermal cell differentiation | 5.438966e-4 |
GO:0016926 | protein desumoylation | 5.548893e-4 |
GO:0006405 | RNA export from nucleus | 5.682688e-4 |
GO:0034470 | ncRNA processing | 6.293750e-4 |
GO:0007214 | gamma-aminobutyric acid signaling pathway | 6.299829e-4 |
GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine | 6.368052e-4 |
GO:0007067 | mitosis | 6.462328e-4 |
GO:0000087 | M phase of mitotic cell cycle | 6.556119e-4 |
GO:0000279 | M phase | 7.297487e-4 |
GO:0000729 | DNA double-strand break processing | 7.395326e-4 |
GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity | 7.476070e-4 |
GO:0014047 | glutamate secretion | 7.587529e-4 |
GO:0008608 | attachment of spindle microtubules to kinetochore | 7.667455e-4 |
GO:0051176 | positive regulation of sulfur metabolic process | 7.863915e-4 |
GO:0031055 | chromatin remodeling at centromere | 7.911064e-4 |
GO:0021603 | cranial nerve formation | 7.959298e-4 |
GO:0048285 | organelle fission | 8.140105e-4 |
GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 8.824365e-4 |
GO:0030510 | regulation of BMP signaling pathway | 8.976776e-4 |
GO:0001835 | blastocyst hatching | 9.667546e-4 |
GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 1.003660e-3 |
GO:0042360 | vitamin E metabolic process | 1.008534e-3 |
GO:0002638 | negative regulation of immunoglobulin production | 1.024448e-3 |
GO:0001811 | negative regulation of type I hypersensitivity | 1.024448e-3 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 1.024587e-3 |
GO:0061014 | positive regulation of mRNA catabolic process | 1.070566e-3 |
GO:0035425 | autocrine signaling | 1.100482e-3 |
GO:0003151 | outflow tract morphogenesis | 1.111051e-3 |
GO:0070194 | synaptonemal complex disassembly | 1.129681e-3 |
GO:0070179 | D-serine biosynthetic process | 1.129681e-3 |
GO:0043297 | apical junction assembly | 1.139637e-3 |
GO:0000079 | regulation of cyclin-dependent protein kinase activity | 1.155009e-3 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 1.171181e-3 |
GO:0072594 | establishment of protein localization to organelle | 1.182203e-3 |
GO:0051298 | centrosome duplication | 1.200162e-3 |
GO:0007389 | pattern specification process | 1.206331e-3 |
GO:0071156 | regulation of cell cycle arrest | 1.210863e-3 |
GO:0051457 | maintenance of protein location in nucleus | 1.225996e-3 |
GO:0019377 | glycolipid catabolic process | 1.246680e-3 |
GO:0042996 | regulation of Golgi to plasma membrane protein transport | 1.354972e-3 |
GO:0050779 | RNA destabilization | 1.396527e-3 |
GO:0016075 | rRNA catabolic process | 1.396527e-3 |
GO:0060420 | regulation of heart growth | 1.462229e-3 |
GO:0071635 | negative regulation of transforming growth factor beta production | 1.499947e-3 |
GO:0021758 | putamen development | 1.541633e-3 |
GO:0021757 | caudate nucleus development | 1.541633e-3 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.542842e-3 |
GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 1.549101e-3 |
GO:0030262 | apoptotic nuclear change | 1.560970e-3 |
GO:0090192 | regulation of glomerulus development | 1.589698e-3 |
GO:0043415 | positive regulation of skeletal muscle tissue regeneration | 1.603770e-3 |
GO:0034660 | ncRNA metabolic process | 1.632910e-3 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 1.651917e-3 |
GO:0072307 | regulation of metanephric nephron tubule epithelial cell differentiation | 1.660239e-3 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 1.733009e-3 |
GO:0007346 | regulation of mitotic cell cycle | 1.761452e-3 |
GO:0090082 | positive regulation of heart induction by negative regulation of canonical Wnt receptor signaling pathway | 1.765805e-3 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 1.765805e-3 |
GO:0021797 | forebrain anterior/posterior pattern specification | 1.779041e-3 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 1.844715e-3 |
GO:0032060 | bleb assembly | 1.885207e-3 |
GO:0001706 | endoderm formation | 1.901951e-3 |
GO:0009057 | macromolecule catabolic process | 1.923128e-3 |
GO:0030163 | protein catabolic process | 1.925942e-3 |
GO:0007501 | mesodermal cell fate specification | 1.987888e-3 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.987888e-3 |
GO:0042268 | regulation of cytolysis | 2.021401e-3 |
GO:0071158 | positive regulation of cell cycle arrest | 2.099781e-3 |
GO:0006306 | DNA methylation | 2.109005e-3 |
GO:0032467 | positive regulation of cytokinesis | 2.170388e-3 |
GO:0007223 | Wnt receptor signaling pathway, calcium modulating pathway | 2.170388e-3 |
GO:0051145 | smooth muscle cell differentiation | 2.226367e-3 |
GO:0090286 | cytoskeletal anchoring at nuclear membrane | 2.271357e-3 |
GO:0034441 | plasma lipoprotein particle oxidation | 2.276637e-3 |
GO:0001555 | oocyte growth | 2.276637e-3 |
GO:0035330 | regulation of hippo signaling cascade | 2.326089e-3 |
GO:0030521 | androgen receptor signaling pathway | 2.341503e-3 |
GO:0090042 | tubulin deacetylation | 2.405533e-3 |
GO:0070846 | Hsp90 deacetylation | 2.405533e-3 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 2.405533e-3 |
GO:0006780 | uroporphyrinogen III biosynthetic process | 2.405533e-3 |
GO:0032365 | intracellular lipid transport | 2.454012e-3 |
GO:0019941 | modification-dependent protein catabolic process | 2.463579e-3 |
GO:0045736 | negative regulation of cyclin-dependent protein kinase activity | 2.538819e-3 |
GO:0050685 | positive regulation of mRNA processing | 2.627610e-3 |
GO:0043484 | regulation of RNA splicing | 2.705217e-3 |
GO:0007619 | courtship behavior | 2.718576e-3 |
GO:0071108 | protein K48-linked deubiquitination | 2.823018e-3 |
GO:0006406 | mRNA export from nucleus | 2.845524e-3 |
GO:0043632 | modification-dependent macromolecule catabolic process | 2.888676e-3 |
GO:0060649 | mammary gland bud elongation | 2.899561e-3 |
GO:0060659 | nipple sheath formation | 2.899561e-3 |
GO:0060003 | copper ion export | 2.899561e-3 |
GO:0015677 | copper ion import | 2.899561e-3 |
GO:0006921 | cellular component disassembly involved in apoptosis | 2.920447e-3 |
GO:0032277 | negative regulation of gonadotropin secretion | 2.932595e-3 |
GO:0031584 | activation of phospholipase D activity | 2.932595e-3 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 2.957803e-3 |
GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation | 3.018220e-3 |
GO:0035852 | horizontal cell localization | 3.018220e-3 |
GO:0035849 | nephric duct elongation | 3.018220e-3 |
GO:0035846 | oviduct epithelium development | 3.018220e-3 |
GO:0035847 | uterine epithelium development | 3.018220e-3 |
GO:0046605 | regulation of centrosome cycle | 3.142686e-3 |
GO:0006493 | protein O-linked glycosylation | 3.203131e-3 |
GO:0003406 | retinal pigment epithelium development | 3.264775e-3 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 3.475975e-3 |
GO:0021516 | dorsal spinal cord development | 3.663167e-3 |
GO:0019376 | galactolipid catabolic process | 3.694655e-3 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 3.694655e-3 |
GO:0006408 | snRNA export from nucleus | 3.830644e-3 |
GO:0002663 | positive regulation of B cell tolerance induction | 3.944121e-3 |
GO:0021549 | cerebellum development | 3.967163e-3 |
GO:0090399 | replicative senescence | 4.009511e-3 |
GO:0014051 | gamma-aminobutyric acid secretion | 4.083635e-3 |
GO:0072520 | seminiferous tubule development | 4.265834e-3 |
GO:0071476 | cellular hypotonic response | 4.265834e-3 |
GO:0035566 | regulation of metanephros size | 4.265834e-3 |
GO:0006302 | double-strand break repair | 4.290081e-3 |
GO:0065004 | protein-DNA complex assembly | 4.399407e-3 |
GO:0046102 | inosine metabolic process | 4.516142e-3 |
GO:0035519 | protein K29-linked ubiquitination | 4.516142e-3 |
GO:0006613 | cotranslational protein targeting to membrane | 4.545796e-3 |
GO:0051973 | positive regulation of telomerase activity | 4.561021e-3 |
GO:0060658 | nipple morphogenesis | 4.561021e-3 |
GO:0045918 | negative regulation of cytolysis | 4.561021e-3 |
GO:0060540 | diaphragm morphogenesis | 4.690855e-3 |
GO:0060464 | lung lobe formation | 4.690855e-3 |
GO:0072289 | metanephric nephron tubule formation | 4.718778e-3 |
GO:0070625 | zymogen granule exocytosis | 4.768594e-3 |
GO:0044314 | protein K27-linked ubiquitination | 4.768594e-3 |
GO:0070163 | regulation of adiponectin secretion | 4.768594e-3 |
GO:0000059 | protein import into nucleus, docking | 4.768594e-3 |
GO:0018214 | protein carboxylation | 4.768594e-3 |
GO:0034641 | cellular nitrogen compound metabolic process | 4.835156e-3 |
GO:2000623 | negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 5.086506e-3 |
GO:0071218 | cellular response to misfolded protein | 5.086506e-3 |
GO:0042667 | auditory receptor cell fate specification | 5.120654e-3 |
GO:0045609 | positive regulation of auditory receptor cell differentiation | 5.120654e-3 |
GO:0060975 | cardioblast migration to the midline involved in heart field formation | 5.120654e-3 |
GO:0035481 | positive regulation of Notch signaling pathway involved in heart induction | 5.120654e-3 |
GO:0034230 | enkephalin processing | 5.120654e-3 |
GO:0034231 | islet amyloid polypeptide processing | 5.120654e-3 |
GO:0003259 | cardioblast anterior-lateral migration | 5.120654e-3 |
GO:0003236 | sinus venosus morphogenesis | 5.120654e-3 |
GO:0003210 | cardiac atrium formation | 5.120654e-3 |
GO:0033152 | immunoglobulin V(D)J recombination | 5.165545e-3 |
GO:0023019 | signal transduction involved in regulation of gene expression | 5.262562e-3 |
GO:0031440 | regulation of mRNA 3'-end processing | 5.408037e-3 |
GO:0007398 | ectoderm development | 5.412675e-3 |
GO:0022617 | extracellular matrix disassembly | 5.549513e-3 |
GO:0051496 | positive regulation of stress fiber assembly | 5.770840e-3 |
GO:0072215 | regulation of metanephros development | 6.141467e-3 |
GO:0032507 | maintenance of protein location in cell | 6.164492e-3 |
GO:0044257 | cellular protein catabolic process | 6.173666e-3 |
GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 6.194198e-3 |
GO:0070562 | regulation of vitamin D receptor signaling pathway | 6.224474e-3 |
GO:0002030 | inhibitory G-protein coupled receptor phosphorylation | 6.224474e-3 |
GO:0001705 | ectoderm formation | 6.224474e-3 |
GO:0072560 | type B pancreatic cell maturation | 6.249596e-3 |
GO:0003283 | atrial septum development | 6.352118e-3 |
GO:0060466 | activation of meiosis involved in egg activation | 6.519997e-3 |
GO:0000738 | DNA catabolic process, exonucleolytic | 6.519997e-3 |
GO:0008053 | mitochondrial fusion | 6.519997e-3 |
GO:0017183 | peptidyl-diphthamide biosynthetic process from peptidyl-histidine | 6.552426e-3 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 6.562765e-3 |
GO:0006450 | regulation of translational fidelity | 6.628837e-3 |
GO:0043153 | entrainment of circadian clock by photoperiod | 6.628837e-3 |
GO:0051586 | positive regulation of dopamine uptake | 6.628837e-3 |
GO:0021930 | cerebellar granule cell precursor proliferation | 6.628837e-3 |
GO:0007052 | mitotic spindle organization | 6.664959e-3 |
GO:0090292 | nuclear matrix anchoring at nuclear membrane | 6.728961e-3 |
GO:0021539 | subthalamus development | 6.728961e-3 |
GO:0035269 | protein O-linked mannosylation | 6.728961e-3 |
GO:0032069 | regulation of nuclease activity | 6.853802e-3 |
GO:0014009 | glial cell proliferation | 6.918772e-3 |
GO:0007031 | peroxisome organization | 6.978581e-3 |
GO:0010721 | negative regulation of cell development | 7.008057e-3 |
GO:0045987 | positive regulation of smooth muscle contraction | 7.129864e-3 |
GO:0060486 | Clara cell differentiation | 7.150446e-3 |
GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 7.649421e-3 |
GO:0045906 | negative regulation of vasoconstriction | 7.649421e-3 |
GO:0016572 | histone phosphorylation | 7.658061e-3 |
GO:0002072 | optic cup morphogenesis involved in camera-type eye development | 7.841488e-3 |
GO:0060022 | hard palate development | 7.841488e-3 |
GO:0022037 | metencephalon development | 7.865428e-3 |
GO:0045792 | negative regulation of cell size | 7.936651e-3 |
GO:0034508 | centromere complex assembly | 7.936651e-3 |
GO:0006401 | RNA catabolic process | 7.958171e-3 |
GO:0032525 | somite rostral/caudal axis specification | 8.090832e-3 |
GO:0060972 | left/right pattern formation | 8.101137e-3 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 8.101137e-3 |
GO:0072221 | metanephric distal convoluted tubule development | 8.138263e-3 |
GO:0061188 | negative regulation of chromatin silencing at rDNA | 8.317301e-3 |
GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein | 8.329119e-3 |
GO:0016558 | protein import into peroxisome matrix | 8.393194e-3 |
GO:0007098 | centrosome cycle | 8.402720e-3 |
GO:0097029 | mature dendritic cell differentiation | 8.407507e-3 |
GO:2000001 | regulation of DNA damage checkpoint | 8.407507e-3 |
GO:0070368 | positive regulation of hepatocyte differentiation | 8.407507e-3 |
GO:0003273 | cell migration involved in endocardial cushion formation | 8.407507e-3 |
GO:2000078 | positive regulation of type B pancreatic cell development | 9.115809e-3 |
GO:0009648 | photoperiodism | 9.115809e-3 |
GO:0009082 | branched chain family amino acid biosynthetic process | 9.361286e-3 |
GO:0008050 | female courtship behavior | 9.586317e-3 |
GO:0046479 | glycosphingolipid catabolic process | 9.586317e-3 |
GO:0090336 | positive regulation of brown fat cell differentiation | 9.612440e-3 |
GO:0090271 | positive regulation of fibroblast growth factor production | 9.612440e-3 |
GO:0090362 | positive regulation of platelet-derived growth factor production | 9.612440e-3 |
GO:0006154 | adenosine catabolic process | 9.612440e-3 |
GO:0046103 | inosine biosynthetic process | 9.612440e-3 |
GO:0032431 | activation of phospholipase A2 activity | 9.612440e-3 |
GO:0097028 | dendritic cell differentiation | 9.654662e-3 |
GO:0035520 | monoubiquitinated protein deubiquitination | 9.654662e-3 |
GO:0000209 | protein polyubiquitination | 9.726266e-3 |
GO:0031109 | microtubule polymerization or depolymerization | 1.018299e-2 |
GO:0021860 | pyramidal neuron development | 1.018299e-2 |
GO:0003285 | septum secundum development | 1.045713e-2 |
GO:0006651 | diacylglycerol biosynthetic process | 1.045713e-2 |
GO:0043538 | regulation of actin phosphorylation | 1.058226e-2 |
GO:0015969 | guanosine tetraphosphate metabolic process | 1.058226e-2 |
GO:0090212 | negative regulation of establishment of blood-brain barrier | 1.058226e-2 |
GO:0014853 | regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction | 1.058226e-2 |
GO:0006666 | 3-keto-sphinganine metabolic process | 1.058226e-2 |
GO:0009236 | cobalamin biosynthetic process | 1.058226e-2 |
GO:0061015 | snRNA import into nucleus | 1.076447e-2 |
GO:0035502 | metanephric ureteric bud development | 1.076447e-2 |
GO:0006683 | galactosylceramide catabolic process | 1.076447e-2 |
GO:0009443 | pyridoxal 5'-phosphate salvage | 1.076447e-2 |
GO:0017187 | peptidyl-glutamic acid carboxylation | 1.076447e-2 |
GO:0007059 | chromosome segregation | 1.112675e-2 |
GO:0032922 | circadian regulation of gene expression | 1.113881e-2 |
GO:0046827 | positive regulation of protein export from nucleus | 1.120537e-2 |
GO:0032774 | RNA biosynthetic process | 1.130317e-2 |
GO:0051313 | attachment of spindle microtubules to chromosome | 1.135221e-2 |
GO:0006390 | transcription from mitochondrial promoter | 1.135841e-2 |
GO:0048854 | brain morphogenesis | 1.139208e-2 |
GO:0003002 | regionalization | 1.146928e-2 |
GO:0072132 | mesenchyme morphogenesis | 1.184865e-2 |
GO:0070979 | protein K11-linked ubiquitination | 1.203878e-2 |
GO:0006269 | DNA replication, synthesis of RNA primer | 1.215815e-2 |
GO:0021568 | rhombomere 2 development | 1.215815e-2 |
GO:0001840 | neural plate development | 1.217394e-2 |
GO:0032202 | telomere assembly | 1.223636e-2 |
GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c | 1.223636e-2 |
GO:0072044 | collecting duct development | 1.236207e-2 |
GO:0006105 | succinate metabolic process | 1.241539e-2 |
GO:0060044 | negative regulation of cardiac muscle cell proliferation | 1.246249e-2 |
GO:0048793 | pronephros development | 1.257080e-2 |
GO:0050768 | negative regulation of neurogenesis | 1.259519e-2 |
GO:0006351 | transcription, DNA-dependent | 1.275333e-2 |
GO:0032331 | negative regulation of chondrocyte differentiation | 1.291486e-2 |
GO:0031323 | regulation of cellular metabolic process | 1.295081e-2 |
GO:0072182 | regulation of nephron tubule epithelial cell differentiation | 1.308627e-2 |
GO:0003323 | type B pancreatic cell development | 1.329520e-2 |
GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway | 1.340913e-2 |
GO:0046092 | deoxycytidine metabolic process | 1.340913e-2 |
GO:0034498 | early endosome to Golgi transport | 1.340913e-2 |
GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response | 1.340913e-2 |
GO:0032608 | interferon-beta production | 1.340913e-2 |
GO:0072488 | ammonium transmembrane transport | 1.345582e-2 |
GO:0071585 | detoxification of cadmium ion | 1.359603e-2 |
GO:2000615 | regulation of histone H3-K9 acetylation | 1.359603e-2 |
GO:0071539 | protein localization to centrosome | 1.359603e-2 |
GO:0060809 | mesodermal to mesenchymal transition involved in gastrulation | 1.359603e-2 |
GO:0006807 | nitrogen compound metabolic process | 1.365627e-2 |
GO:0006264 | mitochondrial DNA replication | 1.367004e-2 |
GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus | 1.404768e-2 |
GO:0003290 | atrial septum secundum morphogenesis | 1.404768e-2 |
GO:0070845 | polyubiquitinated misfolded protein transport | 1.408769e-2 |
GO:0061301 | cerebellum vasculature morphogenesis | 1.408769e-2 |
GO:2000778 | positive regulation of interleukin-6 secretion | 1.408769e-2 |
GO:0030421 | defecation | 1.408769e-2 |
GO:0032074 | negative regulation of nuclease activity | 1.408769e-2 |
GO:0051466 | positive regulation of corticotropin-releasing hormone secretion | 1.408769e-2 |
GO:0071845 | cellular component disassembly at cellular level | 1.414816e-2 |
GO:0031018 | endocrine pancreas development | 1.450233e-2 |
GO:0060430 | lung saccule development | 1.457871e-2 |
GO:0001707 | mesoderm formation | 1.476123e-2 |
GO:0003272 | endocardial cushion formation | 1.519560e-2 |
GO:0090381 | regulation of heart induction | 1.523278e-2 |
GO:0090361 | regulation of platelet-derived growth factor production | 1.523278e-2 |
GO:0019673 | GDP-mannose metabolic process | 1.523278e-2 |
GO:0001832 | blastocyst growth | 1.553743e-2 |
GO:0033365 | protein localization to organelle | 1.556589e-2 |
GO:0000819 | sister chromatid segregation | 1.578983e-2 |
GO:0035434 | copper ion transmembrane transport | 1.588838e-2 |
GO:0032446 | protein modification by small protein conjugation | 1.589549e-2 |
GO:0072054 | renal outer medulla development | 1.593327e-2 |
GO:0046620 | regulation of organ growth | 1.606459e-2 |
GO:0070842 | aggresome assembly | 1.607403e-2 |
GO:0030422 | production of siRNA involved in RNA interference | 1.607403e-2 |
GO:0043985 | histone H4-R3 methylation | 1.607403e-2 |
GO:0042424 | catecholamine catabolic process | 1.626677e-2 |
GO:0061205 | paramesonephric duct development | 1.626677e-2 |
GO:0006116 | NADH oxidation | 1.626677e-2 |
GO:0055118 | negative regulation of cardiac muscle contraction | 1.632577e-2 |
GO:0050774 | negative regulation of dendrite morphogenesis | 1.632577e-2 |
GO:0051303 | establishment of chromosome localization | 1.652721e-2 |
GO:0051171 | regulation of nitrogen compound metabolic process | 1.652974e-2 |
GO:0071285 | cellular response to lithium ion | 1.654207e-2 |
GO:0034645 | cellular macromolecule biosynthetic process | 1.656345e-2 |
GO:0007093 | mitotic cell cycle checkpoint | 1.701626e-2 |
GO:0042119 | neutrophil activation | 1.724016e-2 |
GO:0070918 | production of small RNA involved in gene silencing by RNA | 1.744014e-2 |
GO:0021527 | spinal cord association neuron differentiation | 1.748014e-2 |
GO:0035054 | embryonic heart tube anterior/posterior pattern specification | 1.781353e-2 |
GO:0002065 | columnar/cuboidal epithelial cell differentiation | 1.781931e-2 |
GO:0072197 | ureter morphogenesis | 1.795030e-2 |
GO:0072076 | nephrogenic mesenchyme development | 1.810359e-2 |
GO:0043697 | cell dedifferentiation | 1.810359e-2 |
GO:0072177 | mesonephric duct development | 1.811331e-2 |
GO:0016180 | snRNA processing | 1.811331e-2 |
GO:0046784 | intronless viral mRNA export from host nucleus | 1.811331e-2 |
GO:0022411 | cellular component disassembly | 1.842529e-2 |
GO:0060433 | bronchus development | 1.846993e-2 |
GO:0045750 | positive regulation of S phase of mitotic cell cycle | 1.853047e-2 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 1.856553e-2 |
GO:0007051 | spindle organization | 1.863039e-2 |
GO:0032006 | regulation of TOR signaling cascade | 1.867098e-2 |
GO:0051542 | elastin biosynthetic process | 1.875899e-2 |
GO:2000256 | positive regulation of male germ cell proliferation | 1.875899e-2 |
GO:0045900 | negative regulation of translational elongation | 1.875899e-2 |
GO:0048553 | negative regulation of metalloenzyme activity | 1.875899e-2 |
GO:0006258 | UDP-glucose catabolic process | 1.875899e-2 |
GO:0006844 | acyl carnitine transport | 1.875899e-2 |
GO:0042231 | interleukin-13 biosynthetic process | 1.875899e-2 |
GO:0051204 | protein insertion into mitochondrial membrane | 1.884959e-2 |
GO:0044338 | canonical Wnt receptor signaling pathway involved in mesenchymal stem cell differentiation | 1.884959e-2 |
GO:0044339 | canonical Wnt receptor signaling pathway involved in osteoblast differentiation | 1.884959e-2 |
GO:0006354 | transcription elongation, DNA-dependent | 1.899066e-2 |
GO:0000959 | mitochondrial RNA metabolic process | 1.901322e-2 |
GO:0071824 | protein-DNA complex subunit organization | 1.909575e-2 |
GO:0048384 | retinoic acid receptor signaling pathway | 1.914686e-2 |
GO:0030889 | negative regulation of B cell proliferation | 1.928064e-2 |
GO:0034501 | protein localization to kinetochore | 1.935518e-2 |
GO:0055119 | relaxation of cardiac muscle | 1.936462e-2 |
GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein | 1.936462e-2 |
GO:0051865 | protein autoubiquitination | 1.944159e-2 |
GO:0072053 | renal inner medulla development | 1.949828e-2 |
GO:0035329 | hippo signaling cascade | 1.967124e-2 |
GO:0050684 | regulation of mRNA processing | 1.980600e-2 |
GO:0006931 | substrate-dependent cell migration, cell attachment to substrate | 1.983062e-2 |
GO:0033084 | regulation of immature T cell proliferation in thymus | 1.985932e-2 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 1.985932e-2 |
GO:0001839 | neural plate morphogenesis | 1.985932e-2 |
GO:0007369 | gastrulation | 1.991789e-2 |
GO:0090184 | positive regulation of kidney development | 2.028450e-2 |
GO:0015812 | gamma-aminobutyric acid transport | 2.054356e-2 |
GO:0046602 | regulation of mitotic centrosome separation | 2.057131e-2 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 2.057131e-2 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 2.057131e-2 |
GO:0000917 | barrier septum formation | 2.057131e-2 |
GO:0090072 | positive regulation of sodium ion transport via voltage-gated sodium channel activity | 2.070912e-2 |
GO:0043491 | protein kinase B signaling cascade | 2.078985e-2 |
GO:0051168 | nuclear export | 2.087004e-2 |
GO:0042796 | snRNA transcription from RNA polymerase III promoter | 2.088604e-2 |
GO:2000002 | negative regulation of DNA damage checkpoint | 2.088604e-2 |
GO:0042795 | snRNA transcription from RNA polymerase II promoter | 2.088604e-2 |
GO:0021588 | cerebellum formation | 2.088604e-2 |
GO:0022004 | midbrain-hindbrain boundary maturation during brain development | 2.088604e-2 |